Early Access — free while we kick the tires
EdgarHawk

Grant J Lamontagne

Director

Director

Latest: Director buying · June 2026

2 filings analyzed · 1 company · Latest 2026-06-09

Companies

Company Buys Sells Direction
Laird Superfood, Inc. LSF 9 0 Net buying

Activity

June 2026
high
Buy
59,950 shares
$197,217
Significance 7/10

Director Grant J Lamontagne purchased 59,950 shares across 4 transactions for $197,217.18 at LSF (avg $3.29), expanding holdings 52.0%.

Grant J Lamontagne executed 4 separate purchases totaling 59,950 shares for $197,217.18 between June 2–5, 2026, increasing his stake from 115,294 shares to 175,244 shares (+52.0%). The blended average price of $3.29 compares to the current price of $3.56, and the stock is up 16.7% over the prior 30 days and up 43.6% over the prior 90 days. His prior 5 purchases at this ticker each realized positive 90-day returns, establishing a consistent pattern of well-timed entry timing at LSF. The company reported $13.9M in quarterly revenue with year-over-year growth of 15.2%, though it remained unprofitable on a full-year basis, suggesting the buying occurred amid revenue momentum but ongoing operational challenges.

high
Buy
30,786 shares
$101,137
Significance 6/10

Director Grant J Lamontagne bought 30,786 shares ($101.1K) in 5 transactions over 9 days at $3.28–$3.30 (blended avg $3.29), raising holdings by +36.4% to 115.3K shares.

Grant J Lamontagne, a director at Laird Superfood, executed 5 separate purchases totaling 30,786 shares for $101,136.80 over May 20–29, 2026, with a blended average price of $3.29 per share. This represents a 36.4% increase in his shareholding from 84.5K to 115.3K shares. The transaction occurred with the stock trading at $3.38 currently, 56.7% below its 52-week high of $7.80, and comes at a time when the company posted a latest quarterly revenue of $13.9M with net income of $1.8M, though the company was unprofitable over its most recent full fiscal year despite showing annual revenue growth of 15.2%. The multi-transaction pattern over 9 days, combined with concentrated accumulation at prices well below the 52-week peak, provides visibility into director-level capital allocation during a period of depressed valuation relative to recent highs.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access